Single vs. multiple operators for chronic total occlusion percutaneous coronary interventions: From the PROGRESS-CTO Registry.


Journal

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
ISSN: 1522-726X
Titre abrégé: Catheter Cardiovasc Interv
Pays: United States
ID NLM: 100884139

Informations de publication

Date de publication:
02 2023
Historique:
revised: 31 12 2022
received: 14 09 2022
accepted: 11 01 2023
pubmed: 26 1 2023
medline: 3 3 2023
entrez: 25 1 2023
Statut: ppublish

Résumé

There is limited data on the impact of a second attending operator on chronic total occlusion (CTO) percutaneous coronary intervention (PCI) outcomes. We analyzed the association between multiple operators (MOs) (>1 attending operator) and procedural outcomes of 9296 CTO PCIs performed between 2012 and 2021 at 37 centers. CTO PCI was performed by a single operator (SO) in 85% of the cases and by MOs in 15%. Mean patient age was 64.4 ± 10 years and 81% were men. SO cases were more complex with higher Japan-CTO (2.38 ± 1.29 vs. 2.28 ± 1.20, p = 0.005) and Prospective Global Registry for the Study of Chronic Total Occlusion Intervention scores (1.13 ± 1.01 vs. 0.97 ± 0.93, p < 0.001) compared with MO cases. Procedural time (131 [87, 181] vs. 112 [72, 167] min, p < 0.001), fluoroscopy time (49 [31, 76] vs. 42 [25, 68] min, p < 0.001), air kerma radiation dose (2.32 vs. 2.10, p < 0.001), and contrast volume (230 vs. 210, p < 0.001) were higher in MO cases. Cases performed by MOs and SO had similar technical (86% vs. 86%, p = 0.9) and procedural success rates (84% vs. 85%, p = 0.7), as well as major adverse complication event rates (MACE 2.17% vs. 2.42%, p = 0.6). On multivariable analyses, MOs were not associated with higher technical success or lower MACE rates. In a contemporary, multicenter registry, 15% of CTO PCI cases were performed by multiple operators. Despite being more complex, SO cases had lower procedural and fluoroscopy times, and similar technical and procedural success and risk of complications compared with MO cases.

Sections du résumé

BACKGROUND
There is limited data on the impact of a second attending operator on chronic total occlusion (CTO) percutaneous coronary intervention (PCI) outcomes.
METHODS
We analyzed the association between multiple operators (MOs) (>1 attending operator) and procedural outcomes of 9296 CTO PCIs performed between 2012 and 2021 at 37 centers.
RESULTS
CTO PCI was performed by a single operator (SO) in 85% of the cases and by MOs in 15%. Mean patient age was 64.4 ± 10 years and 81% were men. SO cases were more complex with higher Japan-CTO (2.38 ± 1.29 vs. 2.28 ± 1.20, p = 0.005) and Prospective Global Registry for the Study of Chronic Total Occlusion Intervention scores (1.13 ± 1.01 vs. 0.97 ± 0.93, p < 0.001) compared with MO cases. Procedural time (131 [87, 181] vs. 112 [72, 167] min, p < 0.001), fluoroscopy time (49 [31, 76] vs. 42 [25, 68] min, p < 0.001), air kerma radiation dose (2.32 vs. 2.10, p < 0.001), and contrast volume (230 vs. 210, p < 0.001) were higher in MO cases. Cases performed by MOs and SO had similar technical (86% vs. 86%, p = 0.9) and procedural success rates (84% vs. 85%, p = 0.7), as well as major adverse complication event rates (MACE 2.17% vs. 2.42%, p = 0.6). On multivariable analyses, MOs were not associated with higher technical success or lower MACE rates.
CONCLUSION
In a contemporary, multicenter registry, 15% of CTO PCI cases were performed by multiple operators. Despite being more complex, SO cases had lower procedural and fluoroscopy times, and similar technical and procedural success and risk of complications compared with MO cases.

Identifiants

pubmed: 36695421
doi: 10.1002/ccd.30564
doi:

Types de publication

Multicenter Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

543-552

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2023 Wiley Periodicals LLC.

Références

Suzuki Y, Tsuchikane E, Katoh O, et al. Outcomes of percutaneous coronary interventions for chronic total occlusion performed by highly experienced Japanese specialists. JACC Cardiovasc Interv. 2017;10:2144-2154.
Konstantinidis NV, Werner GS, Deftereos S, et al. Temporal trends in chronic total occlusion interventions in Europe. Circ Cardiovas Interv. 2018;11:e006229.
Quadros A, Belli KC, Paula JET, et al. Chronic total occlusion percutaneous coronary intervention in Latin America. Catheter Cardiovasc Interv. 2020;96:1046-1055.
Xenogiannis I, Gkargkoulas F, Karmpaliotis D, et al. Temporal trends in chronic total occlusion percutaneous coronary interventions: insights from the PROGRESS-CTO registry. J Invasive Cardiol. 2020;32:153-160.
Karmpaliotis D, Lembo N, Kalynych A, et al. Development of a high-volume, multiple-operator program for percutaneous chronic total coronary occlusion revascularization: procedural, clinical, and cost-utilization outcomes. Catheter Cardiovasc Interv. 2013;82:1-8.
Kaul P, Kandzari DE. Chronic total occlusions: practice makes perfect-implications for standardizing performance and training. Circ Cardiovasc Interv. 2020;13:e009724.
Riley RF. Complex, higher-risk, and indicated PCI (CHIP) fellowship. JACC. 2020;75:980-984.
Knaapen P, Henriques JP, Nap A, Arslan F. Percutaneous coronary intervention for chronic total coronary occlusion: do or do not. Neth Heart J. 2021;29:1-3.
Kovach CP, Hebbe A, Barón AE, et al. Clinical characteristics and outcomes among patients undergoing high-risk percutaneous coronary interventions by single or multiple operators: insights from the veterans affairs clinical assessment, reporting, and tracking program. J Am Heart Assoc. 2021;10:e022131.
Harris PA, Taylor R, Minor BL, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inf. 2019;95:103208.
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42:377-381.
Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. Third universal definition of myocardial infarction. Circulation. 2012;126:2020-2035.
Morino Y, Abe M, Morimoto T, et al. Predicting successful guidewire crossing through chronic total occlusion of native coronary lesions within 30 minutes. JACC Cardiovasc Interv. 2011;4:213-221.
Christopoulos G, Kandzari DE, Yeh RW, et al. Development and validation of a novel scoring system for predicting technical success of chronic total occlusion percutaneous coronary interventions. JACC Cardiovasc Interv. 2016;9:1-9.
Lee J, Moses JW, Kirtane AJ. How many operators are optimal for higher-risk percutaneous coronary intervention procedures? J Am Heart Assoc. 2021;10:e023567.
Wu EB, Brilakis ES, Mashayekhi K, et al. Global chronic total occlusion crossing algorithm. JACC. 2021;78:840-853.
Carlino M, Azzalini L, Colombo A. A novel maneuver to facilitate retrograde wire externalization during retrograde chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2017;89:E7-E12.
Hall AB, Xenogiannis I, Burke MN, Brilakis ES. A case-based illustration of a dual-operator, dual microcatheter technique for side branch wiring. Cardiovasc Revascul Med. 2019;20:21-25.

Auteurs

Judit Karacsonyi (J)

Minneapolis Heart Institute, Abbott Northwestern Hospital and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Khaldoon Alaswad (K)

Henry Ford Hospital, Detroit, Michigan, USA.

Oleg Krestyaninov (O)

Meshalkin Novosibirsk Research Institute, Novosibirsk, Russia.

Dimitri Karmpaliotis (D)

Morristown Medical Center, Gagnon Cardiovascular Institute, Morristown, New Jersey, USA.

Ajay Kirtane (A)

Columbia University, New York, New York, USA.

Ziad Ali (Z)

St. Francis Hospital and Heart Center, Roslyn, New York, USA.

Margaret McEntegart (M)

Columbia University, New York, New York, USA.

Amirali Masoumi (A)

Morristown Medical Center, Gagnon Cardiovascular Institute, Morristown, New Jersey, USA.

Paul Poomipanit (P)

Harrington Heart and Vascular Institute, University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA.

Farouc A Jaffer (FA)

Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Jaikirshan Khatri (J)

Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA.

James Choi (J)

Baylor Heart and Vascular Hospital, Baylor University Medical Center, Dallas, Texas, USA.

Mitul Patel (M)

Division of Cardiovascular Medicine, University of California San Diego, La Jolla, California, USA.

Michalis Koutouzis (M)

2nd Department of Cardiology, Red Cross Hospital of Athens, Athens, Greece.

Sevket Gorgulu (S)

Department of Cardiology, Biruni University Medical School, Istanbul, Turkey.

Abdul M Sheikh (AM)

Wellstar Health System, Marietta, Georgia, USA.

Basem Elbarouni (B)

Department of Internal Medicine, Section of Cardiology, St. Boniface General Hospital, Winnipeg, Manitoba, Canada.

Wissam Jaber (W)

Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA.

Ahmed ElGuindy (A)

Aswan Heart Centre, Magdi Yacoub Foundation, Aswan, Egypt.

Robert Yeh (R)

Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

Spyridon Kostantinis (S)

Minneapolis Heart Institute, Abbott Northwestern Hospital and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Bahadir Simsek (B)

Minneapolis Heart Institute, Abbott Northwestern Hospital and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Bavana Rangan (B)

Minneapolis Heart Institute, Abbott Northwestern Hospital and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Olga C Mastrodemos (OC)

Minneapolis Heart Institute, Abbott Northwestern Hospital and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Evangelia Vemmou (E)

Minneapolis Heart Institute, Abbott Northwestern Hospital and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Ilias Nikolakopoulos (I)

Minneapolis Heart Institute, Abbott Northwestern Hospital and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Imre Ungi (I)

Division of Invasive Cardiology, Department of Internal Medicine and Cardiology Center, University of Szeged, Szeged, Hungary.

Nidal A Rafeh (NA)

North Oaks Health System, Hammond, Los Angeles, USA.

Omer Goktekin (O)

Department of Cardiology, Memorial Bahcelievler Hospital, Istanbul, Turkey.

M Nicholas Burke (MN)

Minneapolis Heart Institute, Abbott Northwestern Hospital and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Emmanouil S Brilakis (ES)

Minneapolis Heart Institute, Abbott Northwestern Hospital and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Yader Sandoval (Y)

Minneapolis Heart Institute, Abbott Northwestern Hospital and Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH